Technically Advanced Products will Drive the Growth of the Protein Expression Market During Forecast Period

Posted on 2019-07-26 by P&S Intelligence in Healthcare // 0 Comments

New York, United States, 2019-Jul-26 — /EPR Network/ — The protein expression market is expected to reach $3.0 billion by 2023. Key factors driving the growth of the market include increasing prevalence of chronic diseases, rise in the availability of funding for protein-based research, technological advancements, growing aging population and increasing growth in the life science sector.

Download free report sample at: https://www.psmarketresearch.com/market-analysis/protein-expression-market/report-sample

Major players in the protein expression industry are developing products with technically advanced features that are designed to produce high protein yield, and maintain a balance of speed and scalability; thereby, enhancing its application in the drug development workflow. One of the recent advanced product launched by the major players in the market include Gibco ExpiCHO expression system, launched in 2015 by Thermo Fisher Scientific Inc., that offers an increase yield of over 100-fold, thereby enabling up to 3g/L of protein yield; in comparison to its previous CHO system. Therefore, technically advanced products will drive the growth of the protein expression market during forecast period.

The major players in the protein expression market are entering into partnerships with other firms to gain a larger share in the market. For instance, in July 2017, LabCorp, a medical laboratory tests and services provider through a national network of primary clinical laboratories and specialty testing group laboratories, and Cancer Genetics, Inc. (CGI), DNA-based cancer diagnostics and services provider, signed agreements with Thermo Fisher Scientific to join the NGS Companion Dx Center of Excellence Program (COEP). As preferred partners, each laboratory will participate in oncology-focused clinical trials in collaboration with pharmaceutical companies and Thermo Fisher. The companies may also qualify for early access to Thermo Fisher’s pipeline of novel platforms and assays to assist with development of Oncomine-branded solutions for clinical and biopharma applications.

Pre-Purchase inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=protein-expression-market

Some of the key players operating in the protein expression market include Thermo Fisher Scientific Inc., Merck KGaA, Genscript Biotech Corporation, Agilent Technologies, Inc., Promega Corporation, Bio-Rad Laboratories, Inc., Qiagen N.V., New England Biolabs Inc., and Lonza Group Ltd.

GLOBAL PROTEIN EXPRESSION MARKET SEGMENTATION
By System

Prokaryotic expression systems
- Escherichia coli systems
- Others
Mammalian cell expression systems
- Chinese hamster ovary systems
- Others
Insect cell expression systems
- Baculovirus systems
- Others
Yeast expression systems
- K. Lactic systems
- Saccharomyces systems
- Pichia systems
- Others
Cell-free expression systems
Algal-based expression systems

By Product and Services

Reagents
Expression vectors
Competent cells
Services
Instruments

By Application

Therapeutic
Industrial
Research

By End User

Pharmaceutical and biotechnology companies
Academic research institutes
Contract research organizations
Others

By Region

North America
- U.S.
- Canada
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle-East and Africa
- South Africa
- Rest of Middle East and Africa

About P&S Intelligence

P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Matched content

Editor’s pick